Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam for Postoperative Delirium in Elderly Gastrectomy Patients
NCT07351474Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jan 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of remimazolam in postoperative delirium (POD) (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Incidence of Postoperative Delirium at Day 3. Started Jan 2026; status: recruiting.
02
Drugs
remimazolam
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT07351474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07351474.